Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug
Source ↗
👁 0
💬 0
Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the drugmaker, amply justify the buzz. The company reports that "participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving ≥30% weight loss, a level long associated with bariatric surgery." Retatrutide is the latest compound to emerge from the r
Comments (0)